Post on 14-Jan-2016
Project no_File reference
IMS Health Baltic • September 2005
Baltic pharma market 1999 – 2004
Developments, changes and possible future trends
2 IMS Health Baltic • September 2005
Project no_File reference
Agenda
• Baltic pharma market• Innovative and Generic segments• New launches• Reimbursed and Non-reimbursed segments
3 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: sales 1999 – 2004, retail prices, Euro
All sums in Euro
635,094,912
548,887,459
512,183,662
513,196,598
404,514,738
344,120,445
0
100,000,000
200,000,000
300,000,000
400,000,000
500,000,000
600,000,000
700,000,000
1999 2000 2001 2002 2003 2004
Baltics
BALT ACG 13.0%
IMS Dataview data, 2004
IMS HEALTH MIDAS®, MAT Dec 2004
2004 Pharma market, Euro
ACG 99-03
World 432 billion 10%
Europe 128 billion 9%
4 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: structure by country in 1999 – 2004, retail prices, %
%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1999 2000 2001 2002 2003 2004
Lithuania Latvia Estonia
EST 21.8%
LV 24.0%
LT 54.2%
2004
IMS Dataview data, 2004
5 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: sales by country 1999 – 2004, retail prices, Euro
All sums in Euro
174,207,088204,382,688
283,350,368 277,586,560301,527,296
344,033,344
113,439,048
128,683,272
128,143,960
138,364,672137,069,104
152,595,104
56,474,309
71,448,778
91,481,558
106,453,142
110,291,059
138,466,464
0
100,000,000
200,000,000
300,000,000
400,000,000
500,000,000
600,000,000
700,000,000
1999 2000 2001 2002 2003 2004
Lithuania Latvia Estonia
EST ACG 19.6%
LV ACG 6.1%
LT ACG 14.6%
IMS Dataview data, 2004
6 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: sales per capita by country 1999 – 2004, retail prices, Euro
All sums in Euro
40.34
49.77
58.4
98.3
86.15
79.3180.96
49.32
55.95
66.35
59.655.71
60.1651.03
78.7876.04
65.34
98.9
0
20
40
60
80
100
120
1999 2000 2001 2002 2003 2004
Lithunia Latvia Estonia
EST ACG 19.6%
LV ACG 6.1%
LT ACG 14.6%
IMS Dataview data, 2004
7 IMS Health Baltic • September 2005
Project no_File reference
Agenda
• Baltic pharma market• Innovative and Generic segments• New launches• Reimbursed and Non-reimbursed segments
8 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: structure in 1999 – 2004, retail prices,%
%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1999 2000 2001 2002 2003 2004
Generics Innovative
IMS Dataview data, 2004
Inno 48.6%
Gen 51.4%
2004
Inno 40.8%
Gen 59.2%
1999
9 IMS Health Baltic • September 2005
Project no_File reference
Estonian pharma market: structure in 1999 – 2004, retail prices, Euro
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1999 2000 2001 2002 2003 2004
Generic Innovative
2004
56.8%
43.2%
IMS Dataview data, 2004
1999
50.7%
49.3%
10 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: sales in 1999 – 2004, retail prices, Euro
All sums in Euro
326,413,431
282,845,530255,851,060
246,443,691
229,686,511203,793,341
308,681,481
266,041,929
256,332,602266,752,907
174,828,227
140,327,104
0
100,000,000
200,000,000
300,000,000
400,000,000
500,000,000
600,000,000
700,000,000
1999 2000 2001 2002 2003 2004
Generics Innovative
ACG Inno 17.1%
ACG Gen 9.9%
BALT ACG 13.0%
IMS Dataview data, 2004
11 IMS Health Baltic • September 2005
Project no_File reference
Estonian pharma market: sales in 1999 – 2004, retail prices, Euro
27,815,51834,672,182
40,056,877
45,729,859
49,737,750
59,857,500
28,658,791
36,776,596
51,424,681
60,723,283 60,553,309
78,608,964
0
20,000,000
40,000,000
60,000,000
80,000,000
100,000,000
120,000,000
140,000,000
160,000,000
1999 2000 2001 2002 2003 2004
Generic Innovative
Estonia ACG 19.6%
ACG
Inno 22.4%
Gen 16.6%
IMS Dataview data, 2004
12 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: structure in 1999 – 2004, units
%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1999 2000 2001 2002 2003 2004
Generics Innovative
IMS Dataview data, 2004
Inno 19.8%
Gen 80.2%
2004
Inov 14.7%
Gen 85.3%
1999
13 IMS Health Baltic • September 2005
Project no_File reference
Estonian pharma market: structure in 1999 – 2004, units
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1999 2000 2001 2002 2003 2004
Generic Innovative
2004
31.6%
68.4%
IMS Dataview data, 2004
1999
25.0%
75.0%
14 IMS Health Baltic • September 2005
Project no_File reference
Agenda
• Baltic pharma market• Innovative and Generic segments• New launches• Reimbursed and Non-reimbursed segments
15 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: structure in 1999 – 2004, retail prices, %
%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1999 2000 2001 2002 2003 2004
Old products New Generics New Innovative
New Inno 27.4%
Old 48.0%
BALT 100%
IMS Dataview data, 2004
New Gen 24.6%
16 IMS Health Baltic • September 2005
Project no_File reference
Estonian pharma market: structure in 1999 – 2004, retail prices, %
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1999 2000 2001 2002 2003 2004
Old products New Generic New Innovative
Estonia
ACG
New Inno 22.1%
Old 56.0%
IMS Dataview data, 2004
New Gen 21.9%
17 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: sales in 1999 – 2004, units
units
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1999 2000 2001 2002 2003 2004
Old products New Generics New Innovative
New Inno 8.2%
Old 56.2%
2004
IMS Dataview data, 2004
New Gen 35.5%
18 IMS Health Baltic • September 2005
Project no_File reference
Estonian pharma market: structure in 1999 – 2004, units
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
1999 2000 2001 2002 2003 2004
Old products New Generic New Innovative
Estonia
2004
New Inno 8.2%
Old 61.0%
IMS Dataview data, 2004
New Gen 30.8%
19 IMS Health Baltic • September 2005
Project no_File reference
4%
8%
2%
35%
10%
33%
30%
37%
22%
3%
5%
2%
16%
7%
19%
20%
7%
8%
0% 5% 10% 15% 20% 25% 30% 35% 40%
Italy
Spain
Japan
Canada
France
UK
Germany
USA
Total
% Share (Value)
% Share (Volume)
Generics’ share in pharma markets
7%
21%
24%
8%
7%
5%
Generics Brands
7% 1%
31% 6%
16% 8%
18% 5%
-3% 2%
11% 6%
% Growth Constant $
Source: IMS HEALTH MIDAS®, MAT Dec 2004
20 IMS Health Baltic • September 2005
Project no_File reference
Agenda
• Baltic pharma market• Innovative and Generic segments• New launches• Reimbursed and Non-reimbursed segments
21 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: RX sales in 2000 – 2004, retail prices, Euro
All sums in Euro
123,360,230144,573,336
195,431,839198,136,900
198,229,056
38,869,727
116,055,673
63,997,34584,059,750
142,894,342136,491,418
133,624,835120,909,921
118,806,838
129,922,527
0
50,000,000
100,000,000
150,000,000
200,000,000
250,000,000
300,000,000
350,000,000
400,000,000
450,000,000
500,000,000
2000 2001 2002 2003 2004
Reimbursed Co-payment Non-reimbursed
IMS Dataview data, 2004National Sick Funds data, 2004
22 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: RX sales structure in 2000 – 2004, retail prices, Euro
%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
2000 2001 2002 2003 2004
Reimbursed Co-payment Non-reimbursed
Non-re 27.6%
Reimb 42.1%
2004
Co-pay 30.3%
IMS Dataview data, 2004National Sick Funds data, 2004
23 IMS Health Baltic • September 2005
Project no_File reference
Estonian pharma market: RX sales structure in 2000 – 2004, %
0%
20%
40%
60%
80%
100%
2000 2001 2002 2003 2004
Reimbursed Co-payment Non-reimbursed
Estonia
20042000
Non-re 13.2%
Co-pay 36.1%
Reimb 50.7%
IMS Dataview data, 2004National Sick Funds data, 2004
24 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: RX reimbursed sales per capita by country in 2004, retail prices, Euro
Euro
32.27
13.08
39.44
27.53
22.53
10.73
28.1
19.85
0 10 20 30 40 50 60 70 80
Lithuania
Latvia
Estonia
Baltics
Reimbursed Co-payment
IMS Dataview data, 2004National Sick Funds data, 2004
25 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: RX reimbursed sales per capita by country in 2004, retail prices, Euro
%
32.27
13.08
39.44
27.53
22.53
10.73
28.1
19.85
0% 20% 40% 60% 80% 100%
Lithuania
Latvia
Estonia
Baltics
Reimbursed Co-payment
IMS Dataview data, 2004National Sick Funds data, 2004
58.4%
54.9%
58.9%
41.6%
45.1%
41.1%
58.1% 41.9%
Reimbursed Co-payment
26 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: RX expenditures per capita by country in 2004, retail prices, Euro
Euro
35,44
19,43
41,73
31,55
37,29
27,32
36,09
33,87
0 20 40 60 80 100
Lithuania
Latvia
Estonia
Baltics
State Out of pocket
IMS Dataview data, 2004National Sick Funds data, 2004
27 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: RX expenditures’ structure per capita by country in 2004, retail prices, Euro
All sums in Euro
35,44
19,43
41,73
31,55
37,29
27,32
36,09
33,87
0% 20% 40% 60% 80% 100%
Lithuania
Latvia
Estonia
Baltics
State Out of pocket
IMS Dataview data, 2004National Sick Funds data, 2004
53.6%
41.6%
48.7%
46.4%
58.4%
51.3%
48.2% 51.8%
State Patient
28 IMS Health Baltic • September 2005
Project no_File reference
European Union: expenses on pharmaceuticals in 2001, USD per capita
2001, OECD Health Data2001, IMS Data2001, National Sick Fund data
105
115
131
132
165
191
200
207
243
291
34
112
85
123
11
161
90
65
101
150
0 50 100 150 200 250 300 350 400 450 500
Greece
Denmark
Netherlands
Finland
Irland
Italy
Sweden
Austria
Germany
France
USD
Public
Private
29 IMS Health Baltic • September 2005
Project no_File reference
European Union: expenses on pharmaceuticals in 2001, USD per capita
13
25
26
33
61
65
68
41
34
47
62
13
40
21
0 50 100 150 200 250 300
Latvia
Estonia
Lithuania
Poland
Slovakia
Hungary
Czech
USD
Public
Private
2001, OECD Health Data2001, IMS Data2001, National Sick Fund data
30 IMS Health Baltic • September 2005
Project no_File reference
European Union: Healthy Life Expectancy (HALE) at birth,years
2001, WHO Data67.8
69.0
69.2
69.6
69.7
69.9
70.1
70.1
70.2
70.2
70.4
70.6
70.9
71.0
71.0
71.3
71.8
65.0 66.0 67.0 68.0 69.0 70.0 71.0 72.0 73.0
EU average
Ireland
Malta
UK
Belgium
Netherlands
Denmark
Finland
Old EU average
Germany
Greece
Luxembourg
Spain
Austria
Italy
France
Sweden
31 IMS Health Baltic • September 2005
Project no_File reference
European Union: Healthy Life Expectancy (HALE) at birth,years
2001, WHO data
60.0
61.1
61.8
62.0
64.1
64.3
64.3
66.2
66.6
66.8
67.7
54.0 56.0 58.0 60.0 62.0 64.0 66.0 68.0 70.0 72.0
Latvia
Lithuania
Hungary
Estonia
Slovakia
Poland
New EU average
Cyprus
Czech
Portugal
Slovenia
32 IMS Health Baltic • September 2005
Project no_File reference
Baltic pharma market: state pharma spending per capita by country planed in 2005, retail prices, Euro
Euro
3.17
6.36
2.29
4.02
5.1
5.31
3.16
4.29
32.27
13.08
39.44
27.53
36.41
15.3
40.63
30.48
0 10 20 30 40 50
Lithuania
Latvia
Estonia
Baltics
Central tenders 2004 Central tenders 2005
Reimbursed 2004 Reimbursed 2005
IMS Dataview data, 2005National Sick Funds data, 2005
Versus 2004
Reimb 3.0%Centr 38.0%
Reimb 17.0%Centr -16.5%
Reimb 12.82%Centr 60.88%
Reimb 10.7%Centr 6.7%
33 IMS Health Baltic • September 2005
Project no_File reference
Conclusions
The Baltic pharma market is very small comparing with other European and Global pharma markets but demonstrates relatively high growth rate.
Generics have substantially higher shares in the Baltic pharma market comparing with the markets of Western Europe and the USA. The total generic segment of the Baltic market has shrank a little during the last years but newly launched generics continued to capture the major share of the new products’ segment in volume and a half of it in value.
The State pharma financing in the Baltic States is among the lowest in the European Union. It is increasing every year but still remains far below the European average.
One of the Health Care efficiency measures in the Baltic Sates - Healthy Life Expectancy at birth (HALE) - is among the lowest in the European Union. A good status of population health is an outcome of many factors, including allocation of sufficient financial recourses for an effective innovative pharmacological treatment.
34 IMS Health Baltic • September 2005
Project no_File reference